VTE Risk Not Elevated in AD Patients on JAK Inhibitors: Study VTE Risk Not Elevated in AD Patients on JAK Inhibitors: Study

Investigators examined the VTE risk in untreated patients with AD versus those without AD, compared with AD patients treated with JAK-inhibitors versus those on placebo or dupilumab.MDedge News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Dermatology News Source Type: news